MENIN inhibitor-based therapy in acute leukemia: latest updates from the 2024 ASH annual meeting
{{output}}
Menin inhibitors (MENINis) represent a novel and promising class of therapeutic agents for acute leukemia (AL). AL subtypes driven by overexpressed HOXA9/MEIS1, such as those characterized by KMT2A-rearranged (KMT2Ar) or NPM1-mutated (NPM1m) AL, display sensit... ...
